Table 5.
Study | Number of hips (patients) | Followup (months)* | Survival (%) | Level of evidence |
---|---|---|---|---|
Early-generation alumina | ||||
Petsatodis et al. [77] (2010) | 85 (78) | 240 | 84‡ | IV |
Huo et al. [37] (1996) | 27 (25) | 73 (60–95) | 85 | IV |
Riska [80] (1993) | 290 (255) | 64 (24–144) | 92 | IV |
Nizard et al. [71] (1992) | 187 (172) | 120 | 83‡ | IV |
Winter et al. [98] (1992) | 100 (100) | NR (120–168) | 75 | IV |
Mahoney and Dimon [55] (1990) | 42 (34) | 51 (27–66) | 83 | IV |
Sedel et al. [85] (1990) | 54 (NR) | NR (24–132) | 96 | IV |
O’Leary et al. [72] (1988) | 69 (62) | 37 (24–52) | 73 | IV |
Late-generation alumina | ||||
Lewis et al. [48] (2010) | 30 (30) | 100 (58–121) | 97 | I |
Bascarevic et al. [4] (2009) | 82 (78) | 51 (34–63) | 100 | I |
Greene et al. [28] (2009) | 103 (97) | 50 (48–64) | 100 | IV |
Capello et al. [10] (2008) | 380 (275) | 96 (60–NR) | 96‡ | I |
Iwakiri et al. [38] (2008) | 82 (77) | 80 (60–100) | 91 | IV |
Ha et al. [31] (2007) | 74 (64) | 66 (60–72) | 100 | IV |
Sugano et al. [90] (2007) | 170 (143) | 72 (60–96) | 99 | III |
Hasegawa et al. [33] (2006) | 35 (30) | 70 (60–77) | 83 | IV |
Murphy et al. [68] (2006) | 194 (173) | 50 (24–108) | 96 | IV |
Yoo et al. [99] (2005) | 93 (79) | 68 (60–73) | 100 | IV |
Bizot et al. [7] (2004) | 71 (62) | 108 | 94‡ | IV |
Alumina composite | ||||
Hamilton et al. [32] (2010) | 177 (NR) | 31 (21–49) | 98 | I |
Lombardi et al. [50] (2010)† | 65 (NR) | 73 (26–108) | 95 | II |
* Values are expressed as mean, with range in parentheses; †study of composite femoral head on pure alumina liner; ‡survivorship at noted followup time; NR = not reported.